• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs.社交焦虑障碍的临床表现及药物治疗反应:病因信念的影响
Psychiatry Res. 2015 Jul 30;228(1):65-71. doi: 10.1016/j.psychres.2015.04.014. Epub 2015 Apr 16.
2
Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.社交焦虑障碍药物治疗反应的预测因素:对3项安慰剂对照的帕罗西汀试验的分析
J Clin Psychiatry. 2002 Feb;63(2):152-5. doi: 10.4088/jcp.v63n0211.
3
A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.南非进行的一项关于帕罗西汀治疗社交恐惧症(社交焦虑症)的双盲安慰剂对照试验。
S Afr Med J. 1999 Apr;89(4):402-6.
4
Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.帕罗西汀治疗广泛性社交恐惧症(社交焦虑症):一项随机对照试验。
JAMA. 1998 Aug 26;280(8):708-13. doi: 10.1001/jama.280.8.708.
5
Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance.社交焦虑障碍的药物治疗:结局的人际预测因子和工作联盟的中介作用。
J Anxiety Disord. 2017 Dec;52:79-87. doi: 10.1016/j.janxdis.2017.10.004. Epub 2017 Nov 6.
6
An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.一项关于帕罗西汀治疗“冒犯型”恐人症和社交焦虑障碍的开放性试验。
Depress Anxiety. 2006;23(3):168-74. doi: 10.1002/da.20153.
7
Clinical experience with paroxetine in social anxiety disorder.帕罗西汀治疗社交焦虑障碍的临床经验。
Int Clin Psychopharmacol. 2000 Jul;15 Suppl 1:S19-24. doi: 10.1097/00004850-200007001-00005.
8
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.文拉法辛缓释剂与安慰剂及帕罗西汀治疗社交焦虑障碍的比较
Arch Gen Psychiatry. 2005 Feb;62(2):190-8. doi: 10.1001/archpsyc.62.2.190.
9
Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial.肉毒杆菌毒素治疗伴有多汗症的社交焦虑障碍:一项安慰剂对照双盲试验。
J Clin Psychiatry. 2006 Jan;67(1):30-6. doi: 10.4088/jcp.v67n0105.
10
Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms.帕罗西汀治疗社交焦虑症:焦虑和抑郁症状变化的中介作用
Compr Psychiatry. 2009 Mar-Apr;50(2):135-41. doi: 10.1016/j.comppsych.2008.06.009. Epub 2008 Aug 23.

引用本文的文献

1
Serotonin-related Mechanisms in the Etiology and Pharmacotherapy of Social Phobia, A Review.社交恐惧症病因学与药物治疗中的血清素相关机制,综述
Galen Med J. 2023 Dec 18;12:e3072. doi: 10.31661/gmj.v12i.3072. eCollection 2023.
2
Change in posttraumatic stress disorder-related thoughts during treatment: Do thoughts drive change when pills are involved?治疗过程中创伤后应激障碍相关思维的变化:药物治疗时思维是否会驱动变化?
J Trauma Stress. 2022 Apr;35(2):496-507. doi: 10.1002/jts.22762. Epub 2021 Dec 31.

本文引用的文献

1
Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: outcomes and moderators.社交恐惧症认知行为疗法与接纳承诺疗法的随机对照试验:结果与调节因素
J Consult Clin Psychol. 2014 Dec;82(6):1034-48. doi: 10.1037/a0037212. Epub 2014 Jul 7.
2
Panic symptom profiles in social anxiety disorder: a person-centered data-analytic approach.社交焦虑障碍中的惊恐症状特征:一种基于个体的数据分析方法。
Behav Res Ther. 2014 May;56:53-9. doi: 10.1016/j.brat.2014.03.004. Epub 2014 Mar 20.
3
Which treatment worked better for whom? Moderators of group cognitive behavioral therapy versus adapted mindfulness based stress reduction for anxiety disorders.哪种治疗方法对谁更有效?团体认知行为疗法与适应型正念减压治疗焦虑症的调节因素。
Behav Res Ther. 2013 Aug;51(8):434-42. doi: 10.1016/j.brat.2013.04.004. Epub 2013 May 2.
4
Patient expectations in internet-based self-help for social anxiety.基于互联网的社交焦虑自助中患者的期望。
Cogn Behav Ther. 2013;42(3):203-14. doi: 10.1080/16506073.2012.759615. Epub 2013 May 22.
5
A model of placebo response in antidepressant clinical trials.抗抑郁药临床试验中安慰剂反应的模型。
Am J Psychiatry. 2013 Jul;170(7):723-33. doi: 10.1176/appi.ajp.2012.12040474.
6
Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder.认知重评自我效能在个体认知行为疗法治疗社交焦虑障碍的效果中起中介作用。
J Consult Clin Psychol. 2012 Dec;80(6):1034-40. doi: 10.1037/a0028555. Epub 2012 May 14.
7
Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder.网络和团体认知行为疗法治疗社交焦虑障碍的临床和遗传结局决定因素。
Acta Psychiatr Scand. 2012 Aug;126(2):126-36. doi: 10.1111/j.1600-0447.2012.01834.x. Epub 2012 Feb 9.
8
Functional impairment in social anxiety disorder.社交焦虑障碍中的功能损害。
J Anxiety Disord. 2012 Apr;26(3):393-400. doi: 10.1016/j.janxdis.2012.01.003. Epub 2012 Jan 16.
9
Why does genetic causal information alter perceived treatment effectiveness? An analogue study.为什么遗传因果信息会改变人们对治疗效果的看法?一项模拟研究。
Br J Health Psychol. 2012 May;17(2):294-313. doi: 10.1111/j.2044-8287.2011.02038.x. Epub 2011 Jul 6.
10
Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy.儿童期虐待与社交焦虑障碍:对症状严重程度和药物治疗反应的影响。
Depress Anxiety. 2012 Feb;29(2):131-8. doi: 10.1002/da.20909. Epub 2011 Nov 7.

社交焦虑障碍的临床表现及药物治疗反应:病因信念的影响

Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs.

作者信息

Cohen Jonah N, Potter Carrie M, Drabick Deborah A G, Blanco Carlos, Schneier Franklin R, Liebowitz Michael R, Heimberg Richard G

机构信息

Department of Psychology, Weiss Hall, Temple University, 1701 North 13th Street, Philadelphia, PA 19122, USA.

Department of Psychiatry, Columbia University, Harness Pavilion, 180 Ft. Washington Avenue, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.

出版信息

Psychiatry Res. 2015 Jul 30;228(1):65-71. doi: 10.1016/j.psychres.2015.04.014. Epub 2015 Apr 16.

DOI:10.1016/j.psychres.2015.04.014
PMID:25920804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4416216/
Abstract

Therapies for social anxiety disorder (SAD) leave many patients symptomatic at the end of treatment and little is known about predictors of treatment response. This study investigated the predictive relationship of patients' etiological attributions to initial clinical features and response to pharmacotherapy. One hundred thirty-seven individuals seeking treatment for SAD received 12 weeks of open treatment with paroxetine. Participants completed the Attributions for the Etiology of Social Anxiety Scale at baseline in addition to measures of social anxiety and depression at baseline and over the course of treatment. A latent class analysis suggested four profiles of etiological beliefs about one's SAD that may be characterized as: Familial Factors, Need to be Liked, Bad Social Experiences, and Diffuse Beliefs. Patients in the more psychosocially-driven classes, Need to be Liked and Bad Social Experiences, had the most severe social anxiety and depression at baseline. Patients in the Familial Factors class, who attributed their SAD to genetic, biological, and early life experiences, had the most rapid response to paroxetine.These results highlight the effect of biological and genetically-oriented etiological beliefs on pharmacological intervention, have implications for person-specific treatment selection, and identify potential points of intervention to augment treatment response.

摘要

社交焦虑障碍(SAD)的治疗方法在治疗结束时仍使许多患者有症状,而且对于治疗反应的预测因素知之甚少。本研究调查了患者的病因归因与初始临床特征及药物治疗反应之间的预测关系。137名寻求SAD治疗的个体接受了为期12周的帕罗西汀开放治疗。参与者在基线时完成了社交焦虑病因量表的归因,此外还在基线和治疗过程中完成了社交焦虑和抑郁的测量。潜在类别分析表明,关于自身SAD的病因信念有四种类型,可能被描述为:家族因素、需要被喜欢、不良社交经历和弥散信念。在心理社会驱动较强的类别(需要被喜欢和不良社交经历)中的患者在基线时社交焦虑和抑郁最为严重。将其SAD归因于遗传、生物学和早期生活经历的家族因素类别中的患者对帕罗西汀反应最快。这些结果突出了生物学和基因导向的病因信念对药物干预的影响,对个性化治疗选择有启示意义,并确定了增强治疗反应的潜在干预点。